Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Pb Multiple | 2.1x - 2.4x | 2.3x |
Historical Pb Multiple | 1.2x - 2.9x | 1.6x |
Fair Value | ¥4.60 - ¥5.09 | ¥4.84 |
Upside | -13.7% - -4.6% | -9.1% |
Benchmarks | - | Full Ticker |
TECON BIOLOGY Co.LTD | 210,000.0% | SZSE:002100 |
Dongrui Food Group Co., Ltd. | 120,100.0% | SZSE:001201 |
Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. | 60,501,600.0% | SHSE:605016 |
Hunan New Wellful Co.,Ltd. | 60,097,500.0% | SHSE:600975 |
Tangrenshen Group Co., Ltd | 256,700.0% | SZSE:002567 |
Shanghai Xuerong Biotechnology Co.,Ltd. | 30,051,100.0% | SZSE:300511 |
Select Price / Book Ratio | ||||||||
Benchmark Companies | ||||||||
2100 | 1201 | 605016 | 600975 | 2567 | 300511 | |||
SZSE:002100 | SZSE:001201 | SHSE:605016 | SHSE:600975 | SZSE:002567 | SZSE:300511 | |||
Historical Net Income Growth | ||||||||
5Y CAGR | -1.3% | NM- | 24.3% | -9.1% | NM- | NM- | ||
3Y CAGR | NM- | NM- | 33.0% | NM- | NM- | NM- | ||
Latest Twelve Months | 144.4% | 87.3% | 35.3% | 125.5% | 55.4% | -51.7% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | 2.0% | -0.6% | 20.0% | -5.0% | -0.8% | -9.6% | ||
Prior Fiscal Year | -7.2% | -49.8% | 22.2% | -21.4% | 0.5% | -7.3% | ||
Latest Fiscal Year | 3.5% | -4.3% | 21.3% | 0.6% | -5.7% | -28.5% | ||
Latest Twelve Months | 3.5% | -4.3% | 22.5% | 4.2% | -1.6% | -30.8% | ||
Return on Equity | ||||||||
5 Year Average Margin | 4.4% | 5.8% | 13.2% | -8.5% | -3.4% | -11.5% | ||
Prior Fiscal Year | -19.0% | -15.6% | 13.5% | -42.3% | 2.2% | -11.4% | ||
Latest Twelve Months | 9.0% | -1.9% | 16.5% | 10.8% | -6.0% | -44.9% | ||
Next Fiscal Year | 8.3% | -40.7% | 19.1% | 19.5% | 7.3% | 36.6% | ||
Two Fiscal Years Forward | 11.0% | 19.3% | 20.3% | 20.1% | 6.6% | 85.6% | ||
Current Trading Multiples | ||||||||
Price / LTM Sales | 0.5x | 2.5x | 6.8x | 1.0x | 0.3x | 1.5x | ||
Price / LTM EPS | 14.4x | -56.8x | 29.9x | 24.4x | -19.2x | -4.8x | ||
Price / Book | 1.2x | 1.1x | 4.7x | 2.5x | 1.2x | 2.5x | ||
Price / Fwd Book | 1.2x | 1.7x | 4.2x | 2.1x | 1.3x | 2.4x | ||
Low | Mid | High | ||||||
Benchmark P/B Ratio | 1.1x | 1.2x | 4.7x | |||||
Historical P/B Ratio | 1.2x | 1.6x | 2.9x | |||||
Selected P/B Multiple | 2.1x | 2.3x | 2.4x | |||||
(x) Book Value | 1,182 | 1,182 | 1,182 |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | 2100 | 1201 | 605016 | 600975 | 2567 | 300511 | |
Value of Common Equity | 8,697 | 3,727 | 8,190 | 7,643 | 6,952 | 2,937 | |
(/) Shares Outstanding | 1,365.3 | 254.9 | 323.1 | 1,261.3 | 1,427.4 | 551.1 | |
Implied Stock Price | 6.37 | 14.62 | 25.35 | 6.06 | 4.87 | 5.33 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
Implied Stock Price (Trading Cur) | 6.37 | 14.62 | 25.35 | 6.06 | 4.87 | 5.33 | |
Trading Currency | CNY | CNY | CNY | CNY | CNY | CNY | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |